Lataa...
Gemcitabine and Chlorotoxin Conjugated Iron Oxide Nanoparticles for Glioblastoma Therapy
Many small-molecule anti-cancer drugs have short blood half-lives and toxicity issues due to non-specificity. Nanotechnology has shown great promise in addressing these issues. Here, we report the development of an anti-cancer drug gemcitabine-conjugated iron oxide nanoparticle for glioblastoma ther...
Tallennettuna:
| Julkaisussa: | J Mater Chem B Mater Biol Med |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4727823/ https://ncbi.nlm.nih.gov/pubmed/26835125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C5TB02123E |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|